Surgical robots don’t improve knee surgery revision rates, study says

2024-02-16

临床结果

Robotically assisted total knee arthroplasty has skyrocketed in popularity, but a new registry data analysis raises some questions about the benefits for knee surgery patients. The analysis of American Joint Replacement Registry (AJRR) data, presented at AAOS 2024 in San Francisco, found that revision rates were similar in conventional and robotic-assisted cementless TKA at two years post-operatively. The study also found that the odds of revision due to infection or mechanical loosening were not significantly different between the two methods. “A lot of single surgeon studies show there is improved precision with robotic-assisted TKA,” Dr. Lucas Nikkel, assistant professor of orthopedic surgery at Johns Hopkins Medicine, said in a news release about the study. “Some studies suggest there may be improved early recovery or less damage to soft tissue. One of the challenges with evaluating this is that many previous studies had significant financial conflicts of interest with the authors. We wanted to evaluate these questions using a registry study to eliminate the potential confounding factors to understand if there is a difference when this technology is applied to a surgery.” Studying the results of robotic knee surgery matters as the field becomes a big business. Ortho device giant Stryker has been grabbing market share amid the rising popularity of its Mako robots. Stryker ended 2023 with 60% of its knee replacement procedures and 34% of its hip replacements in the U.S. performed using the robotic system. The percentages were 40% of knees and nearly 20% of hips worldwide. In recent years, competitors including Johnson & Johnson’s DePuy Synthes business, Zimmer Biomet, and Smith+Nephew have entered the market with their own robotic systems. The researchers acknowledged some limitations to the new knee surgery study. National registries such as AJRR rely on the accuracy of data submitted. About 60% of the TKAs on the AJRR register did not report whether or not robotic assistance was used. In addition, the study did not include younger patients. The new study identified 9,220 cementless TKAs, nearly half of which were performed with robotic assistance. The results — which used a multivariable, mixed-effects logistic regression model with controlling for cofounders — included: The odds of all-cause revision at two years following surgery were similar between the conventional and robotic-assisted cohorts (odds ratio 0.8, 95% CI .05 to 1.3; p=0.4). The odds of revision due to infection were similar between the two groups (OR 1.47 95% CI 0.8 to 2.6; p=0.19). Mechanical loosing was not significantly different between the cohorts (OR 3.2, 95% CI 0.8-12; p=0.09). “Utilizing patients over age 65, we expected them to have higher failure rates as the potential for biologic fixation may be slightly lower,” Nikkel said. “We found there was no significant differences in the risk of needing another operation within the first two years after surgery with a robotic-assisted or manual technique. This is significant in this population as the likelihood of an early failure is pretty much the same whether robotic assistance is used or not. Some patients desire a robotic-assisted TKA because they’ve heard it is better, but we’ve shown that there isn’t a true benefit in terms of the likelihood of needing another surgery in the early period.”

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构

Johns Hopkins Medicine, Inc.